SPEAKER_00 0:00

Imagine failing, like an exhausting, really painful physical test, and society just looks at you and tells you that collapsing from it is, you know, just normal.

SPEAKER_01 0:10

Right. They just say that's just how it is.

SPEAKER_00 0:11

Yeah, exactly. So today on the deep dive, we are getting into a fascinating clinical piece by Dr. William Ayrd about von Willebrand disease in women.

SPEAKER_01 0:20

It's a really eye-opening paper.

SPEAKER_00 0:21

It really is. And we're using his insights to uncover how human biology and honestly societal gaslighting kind of team up to hide this systemic bleeding disorder right in plain sight.

SPEAKER_01 0:33

Yeah, we're looking at a pretty profound medical and social paradox today. I mean, this is a condition where normal female biology repeatedly exposes an inherited bleeding disorder. But at the exact same time, societal and familial norms are like working overtime to hide it.

SPEAKER_00 0:48

Right. And our mission today is to untangle that web. So whether you're a medical professional trying to better serve your patients, or maybe you're someone navigating this frustrating maze of the healthcare system yourself, or you know, if you just love connecting the dots between how our bodies work and how society interprets them, this deep dive is going to fundamentally change how you view normal symptoms.

SPEAKER_01 1:09

Absolutely.

SPEAKER_00 1:09

We're basically unpacking the hidden generational toll of normalized pain. So to start us off, we need to establish the biological baseline, right? Because von Willebrand disease or VWD, it isn't actually a female disease, is it?

SPEAKER_01 1:26

No, not at all. Inherently it's not. It is usually inherited in an autosomal pattern.

SPEAKER_00 1:30

Aaron Powell Okay, let's unpack this. Autosomal basically means the mutated gene isn't located on the X or Y sex chromosomes.

SPEAKER_01 1:36

Right. It's on one of the non-sex chromosomes.

SPEAKER_00 1:38

So it affects males and females completely equally. It's just a genetic role of the dice, regardless of your biological sex.

SPEAKER_01 1:44

Exactly. And that genetic role results in a defect in something called von Willebrand factor. Aaron Powell Which is uh what exactly So think of this factor as the essential molecular glue in your bloodstream.

SPEAKER_00 1:56

Okay, glue.

SPEAKER_01 1:57

Right. When a blood vessel is injured, platelets rush to the site to form an initial plug, and von Willebrand factor is the adhesive that helps those platelets actually stick to the injured tissue and to each other. God. In hematology, we call this process primary hemostasis.

SPEAKER_00 2:13

Aaron Powell So if a young boy and a young girl have the exact same defect in this molecular glue, they should look medically identical in childhood.

SPEAKER_01 2:21

They absolutely should, yeah.

SPEAKER_00 2:22

Like they scrape a knee on the playground, maybe they get a few extra bruises or, you know, an occasional bloody nose, but it's mild. It doesn't disrupt their lives at all.

SPEAKER_01 2:30

Well, what's fascinating here is how the clinical picture diverges sharply at Minark.

SPEAKER_00 2:35

Right. The onset of the first menstrual period.

SPEAKER_01 2:37

Exactly. The male patient might remain largely untested by his biology. His need for that molecular glue is only triggered by unpredictable external events like uh a dental extraction.

SPEAKER_00 2:50

Or a sports injury.

SPEAKER_01 2:51

Yeah, or a car accident. But the female patient, she faces a profound physiologic challenge every single month.

SPEAKER_00 2:57

Okay, let's expand on an analogy here to really visualize this. It's like having a faulty plumbing valve in your house, but the issue isn't just a loose valve. The pipes themselves are held together with defective glue.

SPEAKER_01 3:12

I like that, yeah.

SPEAKER_00 3:12

So for a guy, the water is turned off most of the time, so you don't really know the valve is broken unless a pipe bursts from a sudden freeze or something. But for a woman, the water gets turned on full blast every single month. It's a massive pressure test on the whole system.

SPEAKER_01 3:26

That's a perfect way to describe it. And the environment of the uterus makes that monthly pressure test uniquely difficult. Because endometrial shedding during menstruation isn't just like surface blood leaking out from a simple cut. Right. It is a highly complex process of tissue repair, and it occurs in what we call a fibronolytic environment.

SPEAKER_00 3:46

Okay, wait, let's define that for you listening. Fibrinolytic. Yeah. So fibrin is the protein that forms the mesh of a blood clot, and vrotic means to break down.

SPEAKER_01 3:56

Yes.

SPEAKER_00 3:56

So we're talking about a clot busting environment.

SPEAKER_01 3:59

Exactly. The body actively produces these clot busting enzymes in the uterus, so the lining can actually shed properly.

SPEAKER_00 4:06

Wow.

SPEAKER_01 4:07

So you are asking a body with a known genetic defect in its primary hemostatic glue to somehow build and maintain a structural plug.

SPEAKER_00 4:16

In a flood of clot-busting enzymes.

SPEAKER_01 4:18

In an environment actively designed to destroy clots.

SPEAKER_00 4:21

It's like trying to build a sand castle while the tide is rushing in, but you're also using dry, crumbly sand instead of wet sand.

SPEAKER_01 4:28

Yes, exactly.

SPEAKER_00 4:29

The body is constantly ringing the alarm bell, the plumbing is failing, the basement is flooding every single month. Which really begs the question if the physical test is failed so spectacularly and so visibly, why on earth isn't this diagnosed immediately?

SPEAKER_01 4:45

And that brings us to the psychological and social barriers. It's what we can call the normal trap.

SPEAKER_00 4:49

The normal trap.

SPEAKER_01 4:50

Yeah. I mean, heavy menstrual bleeding is incredibly common, but common does not mean normal. The source material points out that fibroids, endocrine disorders, structural issues, they can all cause heavy bleeding. But the trap lies in how this specific inherited bleeding is experienced and interpreted within a family.

SPEAKER_00 5:09

Because VWD is often inherited in an autosomal dominant pattern. Right. Which means a person only needs to inherit the defective gene from one parent to have the disease. It travels super visibly down family lines.

SPEAKER_01 5:22

And because of that dominance, abnormal bleeding literally becomes the family standard. Oh wow. Inherited bleeding can be normalized precisely because it is inherited. Think about a 13-year-old girl who might be terrified because she's bleeding through her clothes at school.

SPEAKER_00 5:37

Which is horrifying at that age.

SPEAKER_01 5:39

Completely. But her mother, who inherited the same dominant gene and went through the exact same ordeal, comforts her by saying, Oh, our periods are just heavy. That's just how it is for the women in our family.

SPEAKER_00 5:50

It's just a generational echo chamber of pain. And, you know, the medical community often reinforces this too.

SPEAKER_01 5:56

They do. A primary care doctor might hear the complaint and just suggest that it's uh hormones settling down during adolescence.

SPEAKER_00 6:03

Right. She'll grow out of it. Yeah. And then patients end up adapting their entire lives around a disease they don't even know they have.

SPEAKER_01 6:09

Yeah, they miss school, they quit sports.

SPEAKER_00 6:11

They set multiple alarms at night, like at 3 a.m., just to change their protection so they don't ruin a mattress, and they just accept this as the standard female experience.

SPEAKER_01 6:21

It's tragic, honestly.

SPEAKER_00 6:22

It really is. But hold on, here's where it gets really interesting. If a patient is bleeding this much and say she needs surgery, shouldn't her basic blood work just be screaming that there's a problem? How does a standard pre-op panel completely miss a systemic bleeding disorder?

SPEAKER_01 6:38

Well, the routine tests doctors use to screen for bleeding disorders before surgery are the PT pro thrombin time and the APTT. Okay. And those tests measure secondary hemostasis, which is the chemical clotting cascade that acts like the rebar, reinforcing that initial platelet pod.

SPEAKER_00 6:54

Okay, so it's a different part of the process.

SPEAKER_01 6:56

Exactly. A normal PT test is actually completely expected in Von Willebrand disease because the PT test does not measure the primary platelet glue. It is looking at an entirely different part of the plumbing system.

SPEAKER_00 7:08

That is incredibly frustrating. The standard test is basically looking for a gas leak when the actual problem is the water pipes.

SPEAKER_01 7:15

That's a great way to put it.

SPEAKER_00 7:17

But what about the other one? The APTT. Does that catch it?

SPEAKER_01 7:20

The APTT test only catches the disorder if the patient's factor eight levels are severely reduced. Factor eight. Yeah. Von Willeburn factor actually carries and protects factor eight in the bloodstream. So if the glue is slightly defective but it's still carrying just enough factor eight, the APTT remains perfectly normal. Wow. The standard tests simply aren't designed to look for this specific molecular defect.

SPEAKER_00 7:43

Aaron Powell So the medical gaslighting continues, but now it's backed by lab results. The doctor sees normal PT and normal APT results and confidently tells the patient her blood clot's perfectly fine.

SPEAKER_01 7:55

Which just reinforces the idea that it's all in her head or just normal.

SPEAKER_00 7:58

Right. But okay, if the routine tests miss it, the logical next step is that a specialist just orders a VWD-specific test.

SPEAKER_01 8:06

Yeah.

SPEAKER_00 8:06

Right. You test the von Willebrand factor itself, and boom, you finally have your diagnosis.

SPEAKER_01 8:11

You'd think so, but even the specific testing holds a biological trap.

SPEAKER_00 8:15

Wait, really?

SPEAKER_01 8:16

Yeah. Von Willebrand factor is what we call an acute phase reactant.

SPEAKER_00 8:20

Okay, let's break that down for the listener. Acute phase reactant, meaning it reacts and spikes during acute medical situations.

SPEAKER_01 8:27

Exactly. When the human body is under severe physical or emotional stress, it naturally releases a massive surge of von Willebrand factor into the bloodstream from its storage sites in the cells. Okay. Acute bleeding, severe inflammation, acute pain, or honestly, even just the anxiety of a difficult blood, all of these trigger that systemic stress response.

SPEAKER_00 8:48

Oh my God. So the body's own panic response is effectively hiding the evidence. It's like a criminal wiping the fingerprints off the crime scene just before the cops arrive. The very act of having a horrific, painful period stresses the body out so much that it pumps extra von Willebrand factor into the blood, which artificially masks the patient's chronically low baseline.

SPEAKER_01 9:11

It's a huge issue. A clinician has to be very intentional to bypass this biological trap. Initial testing needs to include three specific metrics to get a clear picture.

SPEAKER_00 9:21

Which are?

SPEAKER_01 9:22

You need VWF antigen, which measures the physical amount of the protein. You need platelet-dependent activity, which measures how well the glue actually works. And you need factor eight levels. Okay. And crucially, if those results come back normal, but the patient has a strong clinical history of bleeding, the test must be repeated when the patient is at their baseline health, not during an acute stress event.

SPEAKER_00 9:44

Right, not when she's actively suffering. But getting that accurate clinical history is notoriously difficult too, because of the normalization we just talked about.

SPEAKER_01 9:51

Oh, absolutely.

SPEAKER_00 9:52

You can't just casually ask a patient, are your periods heavy? Women will often just say no, because their baseline for heavy is totally skewed by their family history.

SPEAKER_01 10:03

Right. They think what they experience is standard.

SPEAKER_00 10:06

Yeah. So doctors have to use validated tools and ask highly specific questions like, do you bleed through your clothes? Are you passing large clots? Do you have to change your protection hourly?

SPEAKER_01 10:18

Yes, the specific questions are vital. And while doctors and patients are navigating this maze of testing, there is a massive hidden toll accumulating in the background.

SPEAKER_00 10:29

The iron deficiency.

SPEAKER_01 10:30

Yes, the iron deficiency.

SPEAKER_00 10:32

The silent thief. For you listening, if you've ever had your blood drawn and were told, you know, your hemoglobin is fine, you aren't anemic, you might want to listen very closely to this next part. Because there is a massive difference between hemoglobin and ferritin.

SPEAKER_01 10:45

There really is. Doctors frequently rely on a standard complete blood count to check hemoglobin levels. And if hemoglobin isn't severely low, they just assume everything is fine. But hemoglobin only tells you if you are actively anemic right now. It does not measure your body's long-term stored iron. For that, you need to test ferritin.

SPEAKER_00 11:03

And they often skip that.

SPEAKER_01 11:05

All the time. A patient can have perfectly normal hemoglobin while their ferritin is completely depleted from years of cumulative blood loss.

SPEAKER_00 11:13

The source material provides a staggering example of this. It mentions a 16-year-old soccer player who had to completely quit the sport due to extreme fatigue. And her hemoglobin was totally normal.

SPEAKER_01 11:25

But her ferritin was at 8 micrograms per liter.

SPEAKER_00 11:28

Eight?

SPEAKER_01 11:29

Yes. That level of iron depletion entirely explains the severe brain fog, the exhaustion, the restless legs she was having. Her body is completely starved of the fundamental building blocks it needs for cellular energy, even without meeting the technical clinical definition of anemia.

SPEAKER_00 11:45

The real tragedy here is treating the symptom while totally ignoring the system. Because the systemic disorder isn't caught, women undergo extreme life-altering treatments just to stop the bleeding.

SPEAKER_01 11:56

Yeah, invasive procedures.

SPEAKER_00 11:58

Endometrial ablations to chemically or thermally destroy the lining of the uterus. Dilation and cured. Full hysterectomies. I mean, the text highlights a 38-year-old mother who had a hysterectomy without anyone ever checking her systemic chemostasis first.

SPEAKER_01 12:14

It happens more often than you'd think.

SPEAKER_00 12:16

They removed an entire organ because they couldn't figure out why it wouldn't stop bleeding.

SPEAKER_01 12:19

If we connect this to the bigger picture, it really highlights a dual approach that is absolutely required for proper medical care. A clinician evaluating bleeding cannot just look at the organ in isolation. Right. They must investigate two distinct questions. Number one, why is this specific site bleeding? And number two, why is this patient unable to stop it normally?

SPEAKER_00 12:42

Because it could absolutely be both things at once. She could have fibroids causing the initial heavy bleeding, and von Wilbrand disease preventing the platelet plug from forming to stop it. But, okay, say a woman finally gets properly diagnosed and treated. The story still isn't over. Her biology and reproductive choices are constantly shifting the terrain over her lifespan. If her body is failing this monthly stress test, what on earth happens when she faces the ultimate hemostatic challenge, which is childbirth?

SPEAKER_01 13:12

Well, pregnancy acts as a fascinating biological trick. It produces a massive physiological rise in von Willebrand factor and factor eight. Oh, really? Yeah. The body is preparing for the immense trauma of delivery, so it naturally shifts hemostasis into overdrive. For many women, particularly those with type 1 VWD, which is a mild quantitative deficiency where the body just doesn't produce quite enough of the factor, their levels will completely enter the normal range by the third trimester.

SPEAKER_00 13:41

So the body temporarily fixes the plumbing right when it needs the system to hold the most pressure.

SPEAKER_01 13:46

That's a good way to look at it, yes.

SPEAKER_00 13:47

That actually sounds like a perfectly timed defense mechanism.

SPEAKER_01 13:49

It is, and it is highly protective for the delivery itself. But it creates a very dangerous vulnerability immediately afterward. That pregnancy-induced rise is temporary. Once the baby is delivered and the physiological stress of pregnancy resolves, those clotting factor levels plummet rapidly back down to the patient's chronically low baseline.

SPEAKER_00 14:09

And usually by the time that floor drops out, the mother has already been discharged from the hospital.

SPEAKER_01 14:14

Exactly.

SPEAKER_00 14:14

She's at home with a newborn, completely unaware that her temporary protection is totally gone.

SPEAKER_01 14:19

This exposes the mother to severe delayed postpartum hemorrhage days or even weeks after childbirth. That is terrifying. It is. Managing a VWD patient through pregnancy requires an incredibly coordinated hemostatic plan. Hematology, obstetrics, and anesthesiology all must collaborate. Even inserting an epidural needle into the spine carries severe neurological risks if the patient's systemic bleeding disorder isn't properly managed at that exact moment.

SPEAKER_00 14:48

Wow. But what about the actual treatment choices for women living with this day-to-day outside of pregnancy? I mean, not everyone is having a baby.

SPEAKER_01 14:55

Sure. The 2021 guidelines offer a really robust framework, and it depends entirely on the patient's reproductive goals. For managing heavy menstrual bleeding in women who do not wish to conceive, they suggest hormonal therapy, like levinergesterol releasing IUDs or tranhexamic acid.

SPEAKER_00 15:13

Okay, let's talk about tranhexamic acid for a second. If the uterus is that highly fibrinolytic clot busting environment we talked about earlier, tranhexamic acid essentially neutralizes those clot busting enzymes, right?

SPEAKER_01 15:25

That is the exact mechanism, yes. Tranexamic acid is an antifibrinolytic. It stops the enzymes from breaking down the fibrin, which allows the patient's inherently weaker platelet plug to actually hold.

SPEAKER_00 15:35

That makes total sense.

SPEAKER_01 15:36

Now, if the patient does wish to conceive, the guidelines still recommend tranhexamic acid, prioritizing it over another common clotting drug called desmopressin, because the treatment approach has to align with preserving fertility and supporting early pregnancy.

SPEAKER_00 15:49

Okay, so she navigates adolescence, she navigates the risks of pregnancy and postpartum, and eventually menopause arrives. The heavy menstrual bleeding finally stops. Can she just wipe her hands and say she's cured?

SPEAKER_01 16:02

That is a very dangerous clinical misconception. Menopause stops the localized uterine bleeding, but it does not cure the systemic von Willebrand disease. Right. Now, VWF levels naturally rise as the human body ages, so an older woman's blood work might suddenly look normal on a standard lab printout. But current clinical guidance is very clear. You do not erase a historical diagnosis just because the lab numbers shift with age.

SPEAKER_00 16:28

Because the systemic defect is still lurking in her genes. If she goes in for a routine colonoscopy or needs a knee replacement surgery or develops a gastrointestinal bleed, she is still at a significantly higher risk for severe complications than someone without the disease. The ghost of the disease is still there.

SPEAKER_01 16:45

Exactly. Menopause ends the monthly stress test. It doesn't end the biological reality of VWD.

SPEAKER_00 16:51

So what does this all mean? When you step back and look at a woman's entire lifespan with this disease, you see this incredible generational burden. I mean, a patient goes through decades of gaslighting, delayed diagnosis, extreme iron fatigue, unnecessary surgeries, and then she has a child. She becomes not just a parent but a fierce medical advocate. She has to fight tooth and nail so her daughter doesn't face the exact same wall of dismissal she did.

SPEAKER_01 17:16

This raises an important question about the structure of our healthcare system itself. Biology alone does not determine these poor patient outcomes. Right. The real enemy here is fragmented care. If the hematologist only looks at the lab values but doesn't understand the patient's reproductive priorities, and the gynecologist only looks at the uterus but doesn't understand the systemic hemostatic defect, the patient falls right through the cracks. Multidisciplinary care is the only path forward.

SPEAKER_00 17:42

It's astonishing how much effort it takes to combat the assumption of normal. Let's wrap this up. What we've seen today is that von Willebrand disease in women isn't just a medical condition, it is a complex web shaped by biology, reproductive physiology, and societal interpretation.

SPEAKER_01 17:59

Yeah. Normal female physiology, you know, menstruation, childbirth, it reveals the disorder. But social normalization, the family history, the dismissal of women's pain, it hides it again. True, comprehensive care means treating the whole picture. Clinicians must control the bleeding, investigate the site, replace the stolen iron, and plan ahead for the next biological challenge before it happens.

SPEAKER_00 18:23

For you listening, let this be a reminder of the absolute power of critical thinking in your own healthcare journey or the journeys of those you love. Never accept that's just how it is in our family as the final answer without asking why. Pain and exhaustion are not just a tax you pay for existing. There is always a mechanism, and you deserve to know what it is.

SPEAKER_01 18:41

It's about shifting the narrative from passive acceptance to active investigation.

SPEAKER_00 18:45

Here's where it gets really interesting, and it's a final thought to leave you with today. We talked about how von Wildebrand factor is an acute phase reactant. The physical stress of bleeding actually causes the body to release chemicals that mask the exact marker used to diagnose it. Right. It is a disease that hides itself using the trauma it inflicts. It makes you wonder how many other medical conditions out there might be hiding in plain sight. Could the very stress of experiencing a disease be the exact mechanism that hides it from our modern lab tests? Keep asking why, and we'll see you on the next deep dive.